TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.60$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NRXS
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
24.9% 17.2% 11.1% 12.3% 13.5% 15.8%
75.1% 82.8% 88.9% 87.7% 86.5% 84.2%
8.6% 7.5% 8.4% 6.9% 7.7% 13.8%
252.9% 167.7% 190.8% 338.5% 333.2% 225.9%
288.6% 192.0% 214.5% 358.6% 353.0% 303.6%
-213.5% -109.1% -125.6% -270.9% -266.5% -219.4%
3.9% 1.4% 15.6% 217.8% 11.2% 2.1%
-193.0% -111.3% -178.0% -594.6% -306.8% -218.5%
16.8% 1.7% 16.0% 218.0% -306.8% –
-193.0% -111.3% -178.0% -594.6% -306.8% -218.5%
-187.3% -108.6% -161.1% -375.1% -294.2% -214.8%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?